Horizon Pharma Plc Stock Fundamentals
Horizon Pharma PLC fundamentals help investors to digest information that contributes to Horizon Pharma's financial success or failures. It also enables traders to predict the movement of Horizon Stock. The fundamental analysis module provides a way to measure Horizon Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Horizon Pharma stock.
Horizon |
Horizon Pharma PLC Company Profit Margin Analysis
Horizon Pharma's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Horizon Pharma Profit Margin | 0.12 % |
Most of Horizon Pharma's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Horizon Pharma PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Horizon Pharma PLC has a Profit Margin of 0.1202%. This is 101.07% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The profit margin for all United States stocks is 109.46% lower than that of the firm.
Horizon Pharma PLC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Horizon Pharma's current stock value. Our valuation model uses many indicators to compare Horizon Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Horizon Pharma competition to find correlations between indicators driving Horizon Pharma's intrinsic value. More Info.Horizon Pharma PLC is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.52 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Horizon Pharma PLC is roughly 1.92 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Horizon Pharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Horizon Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Horizon Pharma's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Horizon Pharma could also be used in its relative valuation, which is a method of valuing Horizon Pharma by comparing valuation metrics of similar companies.Horizon Pharma is currently under evaluation in profit margin category among its peers.
Horizon Fundamentals
Return On Equity | 0.0854 | |||
Return On Asset | 0.0444 | |||
Profit Margin | 0.12 % | |||
Operating Margin | 0.18 % | |||
Current Valuation | 26.87 B | |||
Shares Outstanding | 229 M | |||
Shares Owned By Insiders | 1.18 % | |||
Shares Owned By Institutions | 98.82 % | |||
Number Of Shares Shorted | 7.1 M | |||
Price To Earning | 32.55 X | |||
Price To Book | 5.10 X | |||
Price To Sales | 6.93 X | |||
Revenue | 3.63 B | |||
Gross Profit | 2.8 B | |||
EBITDA | 1.11 B | |||
Net Income | 521.48 M | |||
Cash And Equivalents | 2.13 B | |||
Cash Per Share | 9.40 X | |||
Total Debt | 2.56 B | |||
Debt To Equity | 0.53 % | |||
Current Ratio | 3.96 X | |||
Book Value Per Share | 23.20 X | |||
Cash Flow From Operations | 1.26 B | |||
Short Ratio | 2.04 X | |||
Earnings Per Share | 1.88 X | |||
Price To Earnings To Growth | 1.00 X | |||
Target Price | 116.5 | |||
Number Of Employees | 2.19 K | |||
Beta | 1.01 | |||
Market Capitalization | 26.63 B | |||
Total Asset | 9.11 B | |||
Retained Earnings | 590.01 M | |||
Working Capital | 2.7 B | |||
Current Asset | 1.11 B | |||
Current Liabilities | 357.55 M | |||
Z Score | 7.48 | |||
Net Asset | 9.11 B |
Pair Trading with Horizon Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Horizon Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Horizon Pharma will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Alcoa Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alcoa Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alcoa Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alcoa Corp to buy it.
The correlation of Alcoa Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alcoa Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alcoa Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alcoa Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Horizon Stock
If you are still planning to invest in Horizon Pharma PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Horizon Pharma's history and understand the potential risks before investing.
Transaction History View history of all your transactions and understand their impact on performance | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
CEOs Directory Screen CEOs from public companies around the world | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |